Skip to main content
BRKR
NASDAQ Industrial Applications And Services

Bruker Q2: Organic Growth Returns, but $135M Goodwill Charge Drives GAAP Loss; FY26 EPS Guidance Reaffirmed at $2.10–$2.15

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$59
Mkt Cap
$9.79B
52W Low
$28.53
52W High
$65.3
52W Position info
107% above low
Off High info
9.6% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BRKR has more than doubled off its 52-week low of $28.53.

Summary

Bruker returned to organic growth in Q2 2026 with BSI bookings up 10% organically, but a $135M goodwill impairment charge drove a GAAP loss. Non-GAAP EPS of $0.49 beat last year, and FY26 guidance was reaffirmed.

Updates

  1. · Dow Jones Newswires — The guidance falls short of the $2.30 consensus, and Q1 net income dropped 79.9% on restructuring charges and asset impairments.


Key Events · Earnings and Guidance · BRKR

  • Q2 Revenue and Organic Growth

    Revenue of $838.5M, up 5.2% yoy; organic growth of 2.8% (3.4% ex-tariff refunds). BSI bookings up 10% organically with book-to-bill >1.0x.

  • Goodwill Impairment Drives GAAP Loss

    A $134.9M non-cash goodwill impairment charge led to a GAAP diluted loss per share of $(0.41), compared to $0.05 EPS in Q2 2025.

  • Non-GAAP Profitability Improves

    Non-GAAP diluted EPS of $0.49 vs. $0.32 yoy; non-GAAP operating margin expanded to 14.1% from 9.0%, driven by cost controls and mix.

  • FY26 Guidance Reaffirmed

    FY26 revenue guidance of $3.54–$3.57B (3–4% reported growth) and non-GAAP EPS of $2.10–$2.15 reaffirmed, with currency and tax adjustments only.


Analysis · BRKR · Industrial Applications And Services

Bruker's Q2 results mark a return to organic revenue growth (+2.8%) and robust BSI bookings (+10% organic), signaling a demand recovery in key end markets like semicon and biopharma. However, a $134.9 million non-cash goodwill impairment charge pushed GAAP results to a loss of $(0.41) per share. Non-GAAP EPS of $0.49 beat the prior year's $0.32, driven by margin expansion. The company reaffirmed its FY26 non-GAAP EPS guidance of $2.10–$2.15, which remains below the $2.30 consensus, but the bookings momentum and margin improvement suggest the worst of the demand softness may be behind them.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BRKR was trading at $59.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.8B. The 52-week trading range was $28.53 to $65.30. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BRKR - Latest Insights

BRKR
Aug 05, 2026, 4:24 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $52.58
Real-time Price: $64.51 info
Change: +$11.93 (+23%) info
Market Cap: $9.865B info
BRKR
Aug 04, 2026, 7:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $59.00
Real-time Price: $64.51 info
Change: +$5.51 (+9%) info
Market Cap: $9.865B info
BRKR
Jul 15, 2026, 7:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $58.97
Real-time Price: $64.51 info
Change: +$5.54 (+9%) info
Market Cap: $9.865B info
BRKR
Jun 12, 2026, 4:15 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $54.23
Real-time Price: $64.51 info
Change: +$10.28 (+19%) info
Market Cap: $9.865B info
BRKR
May 07, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $43.73
Real-time Price: $64.51 info
Change: +$20.78 (+48%) info
Market Cap: $9.865B info